OLIGODENDROGLIOMAS

被引：9

作者：

PETERSON, K

CAIRNCROSS, JG

机构：

[1] UNIV WESTERN ONTARIO,DEPT CLIN NEUROL SCI,LONDON,ON,CANADA

[2] UNIV WESTERN ONTARIO,DEPT NEUROL,LONDON,ON,CANADA

[3] LONDON REG CANC CTR,LONDON,ON N6A 4L6,CANADA

来源：

NEUROLOGIC CLINICS | 1995年 / 13卷 / 04期

关键词：

D O I：

10.1016/S0733-8619(18)30022-7

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Although oligodendrogliomas cannot be considered benign tumors, many are slow-growing indolent tumors for which prolonged life expectancy is the rule. Others behave in a more aggressive, malignant fashion, as their histologic characteristics would predict. The treatment for oligodendrogliomas is evolving, with conservative management still reserved for nonanaplastic tumors, and increasingly aggressive systemic therapies are being developed for more aggressive or recurrent tumors.

引用

页码：861 / &

共 74 条

[1] CEREBRAL GANGLIOGLIOMA WITH ANAPLASTIC OLIGODENDROGLIAL COMPONENT [J].

ALLEGRANZA, A ;

PILERI, S ;

FRANK, G ;

FERRACINI, R .

HISTOPATHOLOGY, 1990, 17 (05) :439-441

[2]

BALKO MG, 1992, HUM PATHOL, V23, P706

[3] MOLECULAR ANALYSIS OF CHROMOSOME-1 ABNORMALITIES IN HUMAN GLIOMAS REVEALS FREQUENT LOSS OF 1P IN OLIGODENDROGLIAL TUMORS [J].

BELLO, MJ ;

VAQUERO, J ;

DECAMPOS, JM ;

KUSAK, ME ;

SARASA, JL ;

SAEZCASTRESANA, J ;

PESTANA, A ;

REY, JA .

INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (02) :172-175

[4]

BISHOP M, 1989, AM J PATHOL, V135, P517

[5]

BROWN M, 1990, Neurology, V40, P397

[6]

BRUNER JM, 1994, SEMIN ONCOL, V21, P126

[7]

BULLARD DE, 1987, CANCER-AM CANCER SOC, V60, P2179, DOI 10.1002/1097-0142(19871101)60:9<2179::AID-CNCR2820600912>3.0.CO

[8]

2-G

[9]

BURGER PC, 1987, CANCER, V59, P1345, DOI 10.1002/1097-0142(19870401)59:7<1345::AID-CNCR2820590719>3.0.CO

[10]

2-A

← 1 2 3 4 5 6 7 8 →